Fiona Gregory Email & Phone Number

Sydney, NSW, AU

Sydney, New South Wales, Australia

Recruited, built and digitally trained a national specialist team ready for a newly approved TGA and then PBS listed product. Implemented a clear strategy with measurable results that a team can get excited about and rewarded for. Planned the CRM system, set KPI’s and budgets to ensure clear ROI on business outcomes. Encouraged an innovative learning.

Sydney, Australia

Promotion of Eligard/BiEligard for Prostate Cancer, Akynzeo/Aloxi for CINV and Folotyn for PTCL.Customers Urologists, Radiation Oncologists, Medical Oncologists, Haematologists, Oncology Pharmacists and RN's.Achievements/Awards. National Oncology Sales Award Winner 2019 National Driving Business Award Winner- Runner up, 2019. How achievedPartnered and.

Sydney, Australia

Promotion of Eligard/BiEligard LHRH for prostate cancer and CXBladdder genomic bladder cancer detection device.Customers KOL's, Urologists, Radiation Oncologists and Medical Oncologists.Market share of Eligard NSW North in Dec 2013 6.9%, in December 2017 13.4%, Evolution Index (EI)120 in 20 million dollar market.CXbladder set up 2nd public hospital key.

Promotion of Nivestim GCSF (1st Biosimilar in Australia), Bondronate (Bisphosphate) and Eligard (LHRH) prostate cancer promotion.Develop and maintain relationships with a variety of customers, KOL's, Haematologists, Medical Oncologists, Urologists, Directors of pharmacy, Oncology pharmacy's, CNE's and RN's.Achievements/AwardsConverted daily filgrastim GCSF.

NSW West

Lead, managed and coached a team of 6 and 8 GP representatives.Aim to exceed sales objectives for Somac PPI and Alvesco ICS AsthmaSept 09 YTD Region Somac 105%, Rank 4th of 11 teams, Alvesco 104%, rank 3rd of 11 teams.Dec 08 YTD Region Somac 102%, Rank 2nd of 11 teams, Alvesco 95%.Individual territory team awards.Low representative turn over

NSW South

Ensure profitatbility of all 6 Specialist and GP Representatives for Lexapro SSRI and Ebixa Alzheimers's disease.Highest regional growth of Lexapro from 6% to 11% over 2 years. 6th to 3rd highest market share increase. Regional Lexapro performance index from 71 to 83.Highest regional Sales vs. Target for Ebixa, 2nd highest regional market share.Low.

Sydney, Australia

Produced, organised and ran initial training courses for new Specialist and GP representative team members.Presented at national, regional conferences and infield training courses.Ensured ROI for all internal and external trainings.Medicine Australia CEP facilitator

Bachelor Of Science (Bsc Hons), Major Physiology/Pharmacology. Minor Psychology

Activities and Societies: Non Portfolio Student Executive Union Officer

A Levels, Maths, Chemistry, Biology, Sociology And General Studies